×
About 7,606 results

ALLMedicine™ Astrocytoma Center

Research & Reviews  3,681 results

Spatial concordance of DNA methylation classification in diffuse glioma.
https://doi.org/10.1093/neuonc/noab134
Neuro-oncology Verburg N, Barthel FP et. al.

May 28th, 2021 - Intratumoral heterogeneity is a hallmark of diffuse gliomas. DNA methylation profiling is an emerging approach in the clinical classification of brain tumors. The goal of this study is to investigate the effects of intratumoral heterogeneity on cl...

Benefit of adjuvant, but not concurrent, temozolomide for IDH-mutant anaplastic astrocy...
https://doi.org/10.1016/S1470-2045(21)00154-6
The Lancet. Oncology; Sasaki H

May 17th, 2021 - Benefit of adjuvant, but not concurrent, temozolomide for IDH-mutant anaplastic astrocytoma.|2021|Sasaki H,|

Secondary cerebellopontine angle oligodendroglioma after cranial irradiation: A case re...
https://doi.org/10.1080/00207454.2021.1929209
The International Journal of Neuroscience; Guo Z, Li D et. al.

May 12th, 2021 - Purpose/Aim: Cerebellopontine angle (CPA) oligodendrogliomas are very rare, and only 3 preoperative cases have been confirmed. Secondary cerebellopontine angle oligodendrogliomas after radiation therapy are exceptionally rare, and no other cases h...

Case report and literature review: antenatal diagnosis of a fetal anaplastic astrocytoma.
https://doi.org/10.1080/14767058.2021.1918668
The Journal of Maternal-fetal & Neonatal Medicine : the O... Huang SJ, Liu XL et. al.

May 10th, 2021 - To describe the ultrasonographic appearance of congenital anaplastic astrocytoma, so as to provide diagnostic clues for it. An updated review of the literature was also carried out. There was a case of fetal anaplastic astrocytoma detected by ultr...

Hypothalamic Pilomyxoid Astrocytoma in a Child with Lipodystrophy.
https://doi.org/10.3174/ajnr.A7136
AJNR. American Journal of Neuroradiology; Benson JC, Trejo-Lopez J et. al.

May 7th, 2021 - Pilomyxoid astrocytoma is a rare form of pediatric CNS malignancy first classified in 2007 by the World Health Organization. The tumors are similar to pilocytic astrocytomas, sharing both some imaging and histologic traits. However, pilomyxoid ast...

see more →

Guidelines  3 results

The role of surgery in the management of patients with diffuse low grade glioma: A syst...
https://doi.org/10.1007/s11060-015-1867-1
Journal of Neuro-oncology; Aghi MK, Nahed BV et. al.

Nov 4th, 2015 - Should patients with imaging suggestive of low grade glioma (LGG) undergo observation versus treatment involving a surgical procedure? These recommendations apply to adults with imaging suggestive of a WHO grade 2 glioma (oligodendroglioma, astroc...

The role of initial chemotherapy for the treatment of adults with diffuse low grade gli...
https://doi.org/10.1007/s11060-015-1931-x
Journal of Neuro-oncology; Ziu M, Kalkanis SN et. al.

Nov 4th, 2015 - Adult patients (older than 18 years of age) with newly diagnosed World Health Organization (WHO) Grade II gliomas (Oligodendroglioma, astrocytoma, mixed oligoastrocytoma). Is there a role for chemotherapy as adjuvant therapy of choice in treatment...

Management of patients with recurrence of diffuse low grade glioma: A systematic review...
https://doi.org/10.1007/s11060-015-1910-2
Journal of Neuro-oncology; Nahed BV, Redjal N et. al.

Nov 4th, 2015 - These recommendations apply to adult patients with recurrent low-grade glioma (LGG) with initial pathologic diagnosis of a WHO grade II infiltrative glioma (oligodendroglioma, astrocytoma, or oligo-astrocytoma). Do pathologic and molecular charac...

see more →

Drugs  53 results see all →

Clinicaltrials.gov  3,815 results

Spatial concordance of DNA methylation classification in diffuse glioma.
https://doi.org/10.1093/neuonc/noab134
Neuro-oncology Verburg N, Barthel FP et. al.

May 28th, 2021 - Intratumoral heterogeneity is a hallmark of diffuse gliomas. DNA methylation profiling is an emerging approach in the clinical classification of brain tumors. The goal of this study is to investigate the effects of intratumoral heterogeneity on cl...

Carmustine - carmustine kit-Sandoz Inc.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=82613f4f-05d1-4410-b288-15b6ad0fd069

May 27th, 2021 - Carmustine for injection is a nitrosourea indicated as palliative therapy as a single agent or in established combination therapy with other approved chemotherapeutic agents in the following: Brain tumors glioblastoma, brainstem glioma, medullobla...

Benefit of adjuvant, but not concurrent, temozolomide for IDH-mutant anaplastic astrocy...
https://doi.org/10.1016/S1470-2045(21)00154-6
The Lancet. Oncology; Sasaki H

May 17th, 2021 - Benefit of adjuvant, but not concurrent, temozolomide for IDH-mutant anaplastic astrocytoma.|2021|Sasaki H,|

Secondary cerebellopontine angle oligodendroglioma after cranial irradiation: A case re...
https://doi.org/10.1080/00207454.2021.1929209
The International Journal of Neuroscience; Guo Z, Li D et. al.

May 12th, 2021 - Purpose/Aim: Cerebellopontine angle (CPA) oligodendrogliomas are very rare, and only 3 preoperative cases have been confirmed. Secondary cerebellopontine angle oligodendrogliomas after radiation therapy are exceptionally rare, and no other cases h...

Case report and literature review: antenatal diagnosis of a fetal anaplastic astrocytoma.
https://doi.org/10.1080/14767058.2021.1918668
The Journal of Maternal-fetal & Neonatal Medicine : the O... Huang SJ, Liu XL et. al.

May 10th, 2021 - To describe the ultrasonographic appearance of congenital anaplastic astrocytoma, so as to provide diagnostic clues for it. An updated review of the literature was also carried out. There was a case of fetal anaplastic astrocytoma detected by ultr...

see more →

News  51 results

Combination Treatment Fails to Improve Survival in Recurrent Glioma
https://www.staging.medscape.com/viewarticle/940391

Nov 4th, 2020 - NEW YORK (Reuters Health) - Following tumor resection in patients with recurrent glioblastoma and anaplastic astrocytoma, treatment with vocimagene amiretrorepvec (Toca 511) and with flucytosine (Toca FC) provides no improvement in overall surviva...

Combination Treatment Fails to Improve Survival in Recurrent Glioma
https://www.medscape.com/viewarticle/940391

Nov 4th, 2020 - NEW YORK (Reuters Health) - Following tumor resection in patients with recurrent glioblastoma and anaplastic astrocytoma, treatment with vocimagene amiretrorepvec (Toca 511) and with flucytosine (Toca FC) provides no improvement in overall surviva...

CHMP recommends approval for generic carmustine
https://www.mdedge.com/hematology-oncology/article/184984/lymphoma-plasma-cell-disorders/chmp-recommends-approval-generic-carmustine
HT Staff

Apr 28th, 2018 - Hodgkin lymphoma Micrograph showing The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion of Carmustine Obvius, a generic version of Carmubris. The CHMP is recommending marketing autho.

Novel Combo Explored for Rare Brain Tumor
https://www.onclive.com/publications/oncology-live/2018/vol-19-no-5/novel-combo-explored-for-rare-brain-tumor

Mar 4th, 2018 - Victor A. Levin, MD Investigators are seeking to determine whether the combination of eflornithine (alphadifluoromethylornithine) with lomustine can improve survival for patients with recurrent anaplastic astrocytoma (AA). A rare form of brain tum...

Severe Headache, Nausea, and Diplopia in a Teenage Girl
https://reference.medscape.com/viewarticle/753945_4

Jan 23rd, 2018 - Intraventricular meningiomas account for 15%-17% of meningiomas in pediatric patients, but only 1.6% of meningiomas in adults.[6] Only 50 reported cases of third ventricle meningioma exist in the literature, and the majority of these lesions are f...

see more →

Patient Education  3 results see all →